IGF-2 and FLT-1/VEGF-R1 mRNA Levels Reveal Distinctions and Similarities Between Congenital and Common Infantile Hemangioma
Open Access
- 1 March 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 63 (3) , 263-267
- https://doi.org/10.1203/pdr.0b013e318163a243
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic FeaturesPediatric and Developmental Pathology, 2003
- Gene quantification using real-time quantitative PCRExperimental Hematology, 2002
- Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysisProceedings of the National Academy of Sciences, 2002
- Noninvoluting Congenital Hemangioma: A Rare Cutaneous Vascular AnomalyPlastic and Reconstructive Surgery, 2001
- Regulation of glut1 mRNA by Hypoxia-inducible Factor-1Journal of Biological Chemistry, 2001
- Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGFJournal of Biological Chemistry, 2000
- GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomasHuman Pathology, 2000
- Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentialsOncogene, 1998
- Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth FactorCell, 1998
- Congenital hemangioma: Evidence of accelerated involutionThe Journal of Pediatrics, 1996